Expanded natural killer cells augment the antimyeloma effect of daratumumab, bortezomib, and dexamethasone in a mouse model
Jaya Lakshmi Thangaraj, Seo-Yeon Ahn, Sung‐Hoon Jung, Manh-Cuong Vo, Tan-Huy Chu, Minh‐Trang Thi Phan, Minsuk Kwon, Kyung‐Hwa Lee, Mihee Kim, Ga‐Young Song, Deok‐Hwan Yang, Jae-Sook Ahn, Hyeoung‐Joon Kim, Duck Cho, Je‐Jung Lee
Topics & Concepts
DaratumumabCancer researchBortezomibImmunotherapyNKG2DImmune systemImmunologyAntibody-dependent cell-mediated cytotoxicityCytotoxicityMedicineAntibodyMonoclonal antibodyMultiple myelomaChemistryIn vitroBiochemistryImmune Cell Function and InteractionMultiple Myeloma Research and TreatmentsCAR-T cell therapy research